Vapaliximab (2D10) is a monoclonal antibody against human VAP-1[1].
References
[1] Salmi M, et al. Developmental regulation of the adhesive and enzymatic activity of vascular adhesion protein-1 (VAP-1) in humans. Blood. 2006 Sep 1;108(5):1555-61. DOI:10.1182/blood-2005-11-4599
